Repair Your Skin While Sleeping on the Softest Bedding!
Combining blissful softness with advanced microfiber technology, Life+Loom sheets with DermaTherapy®'s medical-grade technology are the world’s first & only bedding clinically proven to provide a better night of sleep & a healthy environment for your body to rest.
Reclaim Your Sleep Again
Soft as Silk, Real Science & Available Without a Prescription
The DermaTherapy fabric used is the first and only bedding with FDA 510(K) clearance. Independent clinical testing has proven the effectiveness of this microfiber technology at treating a range of skin & health conditions.
The Department of Dermatology, School of Medicine at Wake Forest University conducted an 8-week clinical trial involving patients with mild eczema and/or psoriasis. Compared to their current cotton bedding, participants saw:
* Statistically significant improvements & reduced severity of atopic dermatitis & itchiness
* Improved skin appearance & moisture
* Better uninterrupted sleep
The Department of Dermatology, School of Medicine at Wake Forest University conducted a 12-week clinical trial involving patients with facial acne. When compared to users of standard pillowcases, our pillowcase users experienced:
* 49% reduction in inflammatory lesions
* 40% reduction in non-inflammatory spots
Our scientists & engineers have developed a uniquely structured micro-fiber that cools & dries by a duel process that wicks away moisture, keeping skin cool and dry. As this moisture evaporates, the surrounding air is cooled through an endothermic process.
Our sheets provide a cooler & dryer night’s sleep even for those suffering from hot flashes.
Clinical studies demonstrate how DermaTherapy's silk-like sheets provide significant improvement across a range of important sleep parameters with study participants experiencing:
* 80% overall sleep improvement
* 80% uninterrupted sleep
* 100% comfort improvement
DermaTherapy's bedding was compared with standard hospital bedding for 307 patients at risk of pressure wound development in an acute-care renal unit over a 6 month period. The study participants experienced:
* 62% fewer bedsores
* 90% more healed sores
* 40% fewer sores at discharge
* 11% fewer days in the hospital